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Re: Meta-analysis of 
Efficacy of Interventions 
Elevated Depressive 
Symptoms in Adults 
Diagnosed With Cancer
Despite the fundamental importance of 
the question of whether interventions can 
reduce depressive symptoms among can-
cer patients, Hart and colleagues (1) had 
to contend with a literature that is limited 
in both quality and quantity of studies in 
their effort to establish basic effect sizes. 
With few studies to begin with, they had 
to eliminate four studies because of incom-
plete data, and they eliminated another 
study as an extreme outlier in effect size. 
They were left with five studies they clas-
sified as psychotherapeutic and four studies 
as pharmacologic.
Three of the studies classified as psy-
chotherapeutic were complex collaborative 
care interventions for depression with med-
ication management components as well as 
psychotherapy components plus additional 
components addressing patient education 
and adherence (2,3). These studies should 
not have been included if the intent was to 
establish the effect size of psychotherapeu-
tic interventions. Whether patients received 
psychotherapy was not determined by rand-
omization and so any evaluation of the spe-
cific contribution of psychotherapy was not 
possible. However, these three studies pro-
vided the bulk (n = 527) of the patients for 
the authors’ calculation of the effect size for 
psychotherapeutic intervention. Of the two 
remaining studies, one randomly assigned 
45 patients to either problem-solving or 
waitlist control groups and retained only 
37 patients for analyses (4). The final study 
(5) contributed two effect sizes based on 
comparisons of 29 patients receiving cogni-
tive behavior therapy and 23 receiving sup-
portive therapy with the same 26-patient 
no-treatment control group, thus violating 
the assumption of independence of effect 
sizes. In sum, the authors identified only 
weak evidence for the efficacy of psycho-
therapeutic interventions from two small 
studies with no control group for minimal 
attention and support.
Of the four pharmacologic studies, one 
(6) substantially differed from the others in 
inadequacies in both its determination of 
depression and its medication management 
by mail, and reduction in depressive symp-
toms was not its primary outcome. Of the 
163 patients randomized to either treat-
ment or control group, only 93 were avail-
able at follow-up. The other three studies 
also involved substantial loss of patients to 
follow-up; one of these studies (7) began 
with a total of 35 patients randomized to 
active medication or placebo and retained 
only 21 at follow-up.
Overall, effect sizes for psychothera-
peutic and pharmacologic interventions 
generated by this meta-analysis are mis-
leading as estimates of the efficacy of 
intervention for depressive symptoms 
among cancer patients. Any verdicts on 
the efficacy of interventions for depressive 
symptoms or calls for these interventions 
to be disseminated and implemented and 
integrated into routine care are prema-
ture. What would seem most appropriate 
is acknowledgment of the weakness of 
available data and the need for more and 
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We appreciate Coyne highlighting several 
of our original points, including the funda-
mental importance of the research question 
and the strikingly small body of relevant 
randomized controlled trials (RCTs). We 
agree that each included RCT had limita-
tions. We concur that dissemination into 
routine care requires additional carefully 
formulated research.
Two primary points of disagreement 
with Coyne remain. First, we contend that 
including collaborative care RCTs and tri-
als with relatively small samples was well 
reasoned. Our goal (p.  991) was to exam-
ine the efficacy of RCTs testing various 
therapeutic approaches rather than specific 
psychotherapies. Collaborative care (CC) 
interventions are well suited for primary 
care (1) and are gaining traction in oncol-
ogy (2). secondary processes in CC, such 
as education about depression, are com-
mon components of psychotherapy (3). 
In the three CC trials, patients were ran-
domly assigned to CC or usual care. We 
emphasized (p. 1000) that patients do not 
invariably receive psychotherapy in a CC 
model but rather can receive psychother-
apy, medication, or both. most CC patients 
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